Weiguo Tan
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Tuberculosis Research and Epidemiology 12
- Epidemiology 10
- Mycobacterium research and diagnosis 6
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- Weiye Yu (9 shared papers)Cheung-Ter Ong (1 shared paper)Qian Gao (6 shared papers)Qingyun Liu (4 shared papers)Qi Jiang (7 shared papers)Howard Takiff (5 shared papers)Zhaofan Luo (1 shared paper)Zuanguang Chen (1 shared paper)
- Journals
- Emerging Microbes & Infections (1 paper)Carbohydrate Polymers (1 paper)PLoS ONE (1 paper)BMC Public Health (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Weiguo Tan
33 papers receiving 524 citations
Peers
Comparison fields: 5 of 95
- Infectious Diseases 238
- Pharmaceutical Science 31
- Epidemiology 125
- Molecular Medicine 18
- Pharmacology 51
Countries citing papers authored by Weiguo Tan
This map shows the geographic impact of Weiguo Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Tan more than expected).
Fields of papers citing papers by Weiguo Tan
This network shows the impact of papers produced by Weiguo Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Tan. The network helps show where Weiguo Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiguo Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 61 | |
| 2 | Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs. | 2007 | 57 |
| 3 | 2019 | 56 | |
| 4 | 2018 | 52 | |
| 5 | 2013 | 52 | |
| 6 | 2022 | 41 | |
| 7 | 2021 | 28 | |
| 8 | 2014 | 27 | |
| 9 | 2020 | 19 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 12 | |
| 12 | 2022 | 9 | |
| 13 | 2019 | 9 | |
| 14 | 2018 | 8 | |
| 15 | 2023 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2018 | 8 | |
| 18 | 1999 | 7 | |
| 19 | 2010 | 7 | |
| 20 | 2019 | 6 |
About Weiguo Tan
Weiguo Tan is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Surgery and Computer Networks and Communications, having authored 34 papers that have together received 529 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (6 papers), Diagnosis and treatment of tuberculosis (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Neurosurgical Procedures and Complications (2 papers), Intracerebral and Subarachnoid Hemorrhage Research (2 papers), Advanced Nanomaterials in Catalysis (2 papers) and Spinal Hematomas and Complications (2 papers). The work is most often cited by research in Infectious Diseases (238 citations), Pharmaceutical Science (31 citations), Epidemiology (125 citations), Molecular Medicine (18 citations) and Pharmacology (51 citations). Weiguo Tan has collaborated with scholars based in China, United States and France. Frequent co-authors include Weiye Yu, Cheung-Ter Ong, Qian Gao, Qingyun Liu, Qi Jiang, Howard Takiff, Zhaofan Luo, Zuanguang Chen, Xing Huang and Duanping Sun. Their work appears in journals such as Emerging Microbes & Infections, Carbohydrate Polymers, PLoS ONE, BMC Public Health and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.